Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT …

In (>5%) of patients with: Postmenopausal osteoporosis were back pain, pain in extremity, hypercholesterolemia, musculoskeletal pain, and cystitis.
Source: back pain